Bridgewater Associates LP bought a new position in Globe Life Inc. (NYSE:GL - Free Report) during the third quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm bought 82,560 shares of the company's stock, valued at approximately $8,744,000. Bridgewater Associates LP owned 0.10% of Globe Life as of its most recent SEC filing.
Several other institutional investors and hedge funds have also made changes to their positions in the business. Riverview Trust Co bought a new position in Globe Life in the third quarter worth approximately $32,000. Benjamin F. Edwards & Company Inc. raised its holdings in Globe Life by 88.4% in the second quarter. Benjamin F. Edwards & Company Inc. now owns 599 shares of the company's stock worth $50,000 after purchasing an additional 281 shares in the last quarter. LRI Investments LLC boosted its holdings in shares of Globe Life by 898.4% in the 2nd quarter. LRI Investments LLC now owns 619 shares of the company's stock valued at $51,000 after buying an additional 557 shares in the last quarter. Family Firm Inc. purchased a new position in shares of Globe Life in the 2nd quarter worth approximately $54,000. Finally, Blue Trust Inc. boosted its stake in Globe Life by 249.5% in the second quarter. Blue Trust Inc. now owns 776 shares of the company's stock valued at $64,000 after acquiring an additional 554 shares in the last quarter. 81.61% of the stock is currently owned by institutional investors.
Globe Life Stock Performance
Shares of NYSE GL traded down $0.36 during midday trading on Friday, reaching $111.34. 311,572 shares of the stock were exchanged, compared to its average volume of 1,486,703. The company has a quick ratio of 0.05, a current ratio of 0.05 and a debt-to-equity ratio of 0.50. The firm has a market cap of $9.35 billion, a price-to-earnings ratio of 9.41 and a beta of 0.81. The firm has a 50-day simple moving average of $108.05 and a two-hundred day simple moving average of $96.33. Globe Life Inc. has a twelve month low of $38.95 and a twelve month high of $132.00.
Globe Life (NYSE:GL - Get Free Report) last released its quarterly earnings results on Wednesday, October 23rd. The company reported $3.49 earnings per share for the quarter, topping analysts' consensus estimates of $3.06 by $0.43. The company had revenue of $1.46 billion during the quarter, compared to analysts' expectations of $1.46 billion. Globe Life had a return on equity of 22.91% and a net margin of 19.04%. Globe Life's quarterly revenue was up 5.1% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $2.71 EPS. As a group, analysts anticipate that Globe Life Inc. will post 12.31 EPS for the current fiscal year.
Globe Life Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, January 31st. Investors of record on Wednesday, January 8th will be issued a $0.24 dividend. This represents a $0.96 annualized dividend and a yield of 0.86%. The ex-dividend date is Monday, January 6th. Globe Life's payout ratio is 8.12%.
Analyst Ratings Changes
Several brokerages recently issued reports on GL. Wells Fargo & Company upped their target price on Globe Life from $108.00 to $117.00 and gave the company an "overweight" rating in a research report on Thursday, October 10th. Keefe, Bruyette & Woods lifted their target price on shares of Globe Life from $120.00 to $125.00 and gave the stock an "outperform" rating in a research note on Tuesday, October 29th. Raymond James boosted their target price on shares of Globe Life from $160.00 to $188.00 and gave the stock a "strong-buy" rating in a research report on Tuesday, October 15th. Morgan Stanley lifted their price objective on shares of Globe Life from $110.00 to $120.00 and gave the stock an "equal weight" rating in a research note on Thursday, October 24th. Finally, TD Cowen started coverage on Globe Life in a research note on Wednesday, October 9th. They issued a "buy" rating and a $150.00 target price for the company. Five investment analysts have rated the stock with a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company's stock. According to data from MarketBeat.com, the company has a consensus rating of "Moderate Buy" and a consensus target price of $124.50.
View Our Latest Research Report on GL
About Globe Life
(
Free Report)
Globe Life Inc, through its subsidiaries, provides various life and supplemental health insurance products, and annuities to lower middle- and middle-income families in the United States. The company operates in four segments: Life Insurance, Supplemental Health Insurance, Annuities, and Investments.
Read More
Before you consider Globe Life, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Globe Life wasn't on the list.
While Globe Life currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2025 and why they should be in your portfolio.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.